Pharmacolog announces the appointment of Anders Hedlund as interim CEO
The Board has decided to appoint Anders Hedlund as interim CEO of the company. He replaces thereby Lars Gusch who will step down to pursue external opportunities as announced in an earlier press release. The replacement of CEO will be in effect from May 1, 2024.Anders Hedlund is currently the CEO of Nolsterby Invest AB, the largest shareholder in Pharmacolog. Nolsterby Invest AB is an investment company in the healthcare sector and has been invested in Pharmacolog since 2017. Since 2023, Anders Hedlund is also a current Board Member of Pharmacolog, a position he plans to maintain. Erik